Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sedlmayr, P.
Right arrow Articles by Dohr, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sedlmayr, P.
Right arrow Articles by Dohr, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 8, No. 4, 385-391, April 2002
© 2002 European Society of Human Reproduction and Embryology


Implantation and pregnancy

Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta

P. Sedlmayr1,6, A. Blaschitz1, R. Wintersteiger2, M. Semlitsch1, A. Hammer1, C.R. MacKenzie4, W. Walcher3, O. Reich3, O. Takikawa5 and G. Dohr1

1 Institut für Histologie und Embryologie, 2 Institut für Pharmazeutische Chemie 3 Geburtshilflich-gynäkologische Universitätsklinik, Karl-Franzens-Universität, Graz, Austria, 4 Institut für Mikrobiologie und Virologie, Heinrich-Heine-Universität, D-40225 Düsseldorf, Germany 5 Department of Pharmacology, Hokkaido University, Sapporo 060-8638, Japan

Indoleamine 2,3-dioxygenase (IDO) has been implicated in regulation of feto-maternal tolerance and protection against intracellular and extracellular pathogens. We have studied the expression of IDO in the human female reproductive tract and the placenta by immunohistochemistry. Endometrial glandular and surface epithelial cells showed increasing IDO expression during the course of the menstrual cycle. In term placenta, IDO was irregularly localized to the mesenchymal core and found in isolated areas of the syncytiotrophoblast. In first trimester pregnancy, IDO was not present in placental villi, but was present in glandular epithelium of the decidua, and there were distinctly positive cells scattered in the connective tissue, sometimes in conjunction with lymphoid aggregates. The endothelium of spiral arteries and of capillaries showed some, albeit no generalized, reactivity. IDO was also present in the epithelium of cervical glands and of Fallopian tubes. Specificity of antibody binding was confirmed by Western blot analysis. IDO mRNA was detected in first trimester decidua as determined by RT–PCR. IDO is secreted, as determined by analysis of cervical mucus by high pressure liquid chromatography for the presence of the tryptophan metabolite L-kynurenine, indicating IDO activity. Our results support the concept of IDO providing a mechanism of innate immunity protecting against ascending infections in the female reproductive tract.

decidua/endometrium/feto-maternal tolerance/mucosal immunity/pregnancy

6 To whom correspondence should be addressed at: Institut für Histologie und Embryologie, Karl-Franzens-Universität, Harrachgasse 21, A-8010 Graz, Austria. E-mail: peter.sedlmayr{at}kfunigraz.ac.at


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Ino, E. Yamamoto, K. Shibata, H. Kajiyama, N. Yoshida, M. Terauchi, A. Nawa, T. Nagasaka, O. Takikawa, and F. Kikkawa
Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
Clin. Cancer Res., April 15, 2008; 14(8): 2310 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Scheler, J. Wenzel, T. Tuting, O. Takikawa, T. Bieber, and D. von Bubnoff
Indoleamine 2,3-Dioxygenase (IDO): The Antagonist of Type I Interferon-Driven Skin Inflammation?
Am. J. Pathol., December 1, 2007; 171(6): 1936 - 1943.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Ueno, S. Cho, L. Cheng, J. Wang, S. Hou, H. Nakano, P. Santamaria, and Y. Yang
Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes
Diabetes, June 1, 2007; 56(6): 1686 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
N. Miwa, S. Hayakawa, S. Miyazaki, S. Myojo, Y. Sasaki, M. Sakai, O. Takikawa, and S. Saito
IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-{gamma} increase in normal pregnancy but decrease in spontaneous abortion
Mol. Hum. Reprod., December 1, 2005; 11(12): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Okamoto, T. Nikaido, K. Ochiai, S. Takakura, M. Saito, Y. Aoki, N. Ishii, N. Yanaihara, K. Yamada, O. Takikawa, et al.
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
Clin. Cancer Res., August 15, 2005; 11(16): 6030 - 6039.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Shao, A. R. Jacobs, V. V. Johnson, and L. Mayer
Activation of CD8+ Regulatory T Cells by Human Placental Trophoblasts
J. Immunol., June 15, 2005; 174(12): 7539 - 7547.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y. Kudo, T. Hara, T. Katsuki, A. Toyofuku, Y. Katsura, O. Takikawa, T. Fujii, and K. Ohama
Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium
Hum. Reprod., May 1, 2004; 19(5): 1222 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Mackler, E. M. Barber, O. Takikawa, and J. W. Pollard
Indoleamine 2,3-Dioxygenase Is Regulated by IFN-{gamma} in the Mouse Placenta During Listeria monocytogenes Infection
J. Immunol., January 15, 2003; 170(2): 823 - 830.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.